BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 31303602)

  • 1. Revascularization Strategies in Patients With STEMI: Culprit-Only vs Multivessel Revascularization Using Percutaneous Coronary Intervention.
    Alsadat N; Hyun K; D'Souza M; Chew D; Weaver J; Juergens C; Kritharides L; Hammett C; Brieger D
    J Invasive Cardiol; 2019 Nov; 31(11):314-318. PubMed ID: 31303602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Hahn JY; Kim HK; Park J; Hwang D; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Kim YJ; Chae SC; Cho MC; Kim CJ; Gwon HC; Kim JH; Kim HS; Jeong MH;
    J Am Coll Cardiol; 2018 Feb; 71(8):844-856. PubMed ID: 29471935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry.
    Galvão Braga C; Cid-Álvarez AB; Redondo Diéguez A; Trillo-Nouche R; Álvarez Álvarez B; López Otero D; Ocaranza Sánchez R; Gestal Romaní S; González Ferreiro R; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):425-432. PubMed ID: 27825718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culprit Vessel-Only vs. Staged Multivessel Percutaneous Coronary Intervention Strategies in Patients With Multivessel Coronary Artery Disease Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Toyota T; Shiomi H; Taniguchi T; Morimoto T; Furukawa Y; Nakagawa Y; Horie M; Kimura T;
    Circ J; 2016; 80(2):371-8. PubMed ID: 26597353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2019 May; 284():102-109. PubMed ID: 30877937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Bangalore S; Toklu B; Stone GW
    Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivessel disease in patients over 75years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI+75 nation-wide registry.
    de La Torre Hernandez JM; Gomez Hospital JA; Baz JA; Brugaletta S; Perez de Prado A; Linares JA; Lopez Palop R; Cid B; Garcia Camarero T; Diego A; Gutierrez H; Fernandez Diaz JA; Sanchis J; Alfonso F; Blanco R; Botas J; Navarro Cuartero J; Moreu J; Bosa F; Vegas JM; Elizaga J; Arrebola AL; Hernandez F; Salvatella N; Monteagudo M; Gomez Jaume A; Carrillo X; Martin Reyes R; Lozano F; Rumoroso JR; Andraka L; Dominguez AJ
    Cardiovasc Revasc Med; 2018; 19(5 Pt B):580-588. PubMed ID: 29306670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies: Insights from the REAL registry.
    Manari A; Varani E; Guastaroba P; Menozzi M; Valgimigli M; Menozzi A; Magnavacchi P; Franco N; Marzocchi A; Casella G
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):912-22. PubMed ID: 24403174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial.
    Wood DA; Cairns JA; Wang J; Mehran R; Storey RF; Nguyen H; Meeks B; Kunadian V; Tanguay JF; Kim HH; Cheema A; Dehghani P; Natarajan MK; Jolly SS; Amerena J; Keltai M; James S; Hlinomaz O; Niemela K; AlHabib K; Lewis BS; Nguyen M; Sarma J; Dzavik V; Della Siega A; Mehta SR;
    J Am Coll Cardiol; 2019 Dec; 74(22):2713-2723. PubMed ID: 31779786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivessel versus culprit-only PCI in STEMI patients with multivessel disease: meta-analysis of randomized controlled trials.
    Feistritzer HJ; Jobs A; de Waha-Thiele S; Eitel I; Freund A; Abdel-Wahab M; Desch S; Thiele H
    Clin Res Cardiol; 2020 Nov; 109(11):1381-1391. PubMed ID: 32239284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial.
    Zeymer U; Werdan K; Schuler G; Zahn R; Neumann FJ; Fürnau G; de Waha S; Schneider S; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):601-609. PubMed ID: 27655918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Culprit vessel only versus complete revascularization following thrombolysis in patients with ST elevation myocardial infraction and multivessel coronary artery disease - A prospective study.
    Jain C; Dash PK; Iyer VR; Deshmukh R
    Indian Heart J; 2023; 75(4):274-278. PubMed ID: 37402433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis.
    Kolte D; Sardar P; Khera S; Zeymer U; Thiele H; Hochadel M; Radovanovic D; Erne P; Hambraeus K; James S; Claessen BE; Henriques JPS; Mylotte D; Garot P; Aronow WS; Owan T; Jain D; Panza JA; Frishman WH; Fonarow GC; Bhatt DL; Aronow HD; Abbott JD
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.
    Mehta SR; Wood DA; Meeks B; Storey RF; Mehran R; Bainey KR; Nguyen H; Bangdiwala SI; Cairns JA;
    Am Heart J; 2019 Sep; 215():157-166. PubMed ID: 31326681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
    Atti V; Gwon Y; Narayanan MA; Garcia S; Sandoval Y; Brilakis ES; Basir MB; Turagam MK; Khandelwal A; Mena-Hurtado C; Mamas MA; Abbott JD; Bhatt DL; Velagapudi P
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1571-1582. PubMed ID: 32646699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction.
    Wang TY; McCoy LA; Bhatt DL; Rao SV; Roe MT; Resnic FS; Cavender MA; Messenger JC; Peterson ED
    Am Heart J; 2016 Feb; 172():9-18. PubMed ID: 26856210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial.
    Mehta SR; Wang J; Wood DA; Spertus JA; Cohen DJ; Mehran R; Storey RF; Steg PG; Pinilla-Echeverri N; Sheth T; Bainey KR; Bangalore S; Cantor WJ; Faxon DP; Feldman LJ; Jolly SS; Kunadian V; Lavi S; Lopez-Sendon J; Madan M; Moreno R; Rao SV; Rodés-Cabau J; Stankovic G; Bangdiwala SI; Cairns JA;
    JAMA Cardiol; 2022 Nov; 7(11):1091-1099. PubMed ID: 36129696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion-Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.
    Marino M; Crimi G; Leonardi S; Ferlini M; Repetto A; Camporotondo R; Demarchi A; De Pascali I; Falcinella F; Oltrona Visconti L; De Servi S; Ferrario M; De Ferrari GM; Gnecchi M
    Am J Cardiol; 2017 Feb; 119(4):508-514. PubMed ID: 28007297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.